Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. The company is also developing AR-320 is a fully human IgG1 monoclonal antibody targeting S. aureus alpha toxin to treat infections caused by methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus; AR-105, a fully human IgG1 mAb, which is in Phase II trials to target gram-negative bacteria P. aeruginosa; AR-101, a human IgM mAb, which is in Phase IIa clinical trials for the treatment of hospital-acquired pneumonia (HAP)and ventilator-associated pneumonia (VAP) caused by P. aeruginosa serotype O11; AR-401 that is in preclinical stage to treat infections caused by Acinetobacter baumannii; AR-201, a fully human IgG1 mAb preclinical program for respiratory syncytial virus; and AR-501, an anti-infective therapy, which is in Phase I/IIa clinical trial to manage chronic lung infections in cystic fibrosis patients. In addition, it is developing AR-712 and AR-701, a cocktail of two fully human immunoglobulin 1, or IgG1, mAbs, which is in Phase I/II clinical for the treatment of mild to moderate non-hospitalized COVID-19 patients. Aridis Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Los Gatos, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Aridis Pharmaceuticals Inc..
Aridis Pharmaceuticals Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Aridis Pharmaceuticals Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Aridis Pharmaceuticals Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Aridis Pharmaceuticals Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Aridis Pharmaceuticals Inc. and all latest updates of the company are provided.
The 2025 version of Aridis Pharmaceuticals Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Aridis Pharmaceuticals Inc.- Key Facts
2.2 Aridis Pharmaceuticals Inc.- Geographic Locations
2.3 Aridis Pharmaceuticals Inc.- Subsidiaries and Affiliates
2.4 Aridis Pharmaceuticals Inc.- Business Divisions
2.5 Aridis Pharmaceuticals Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Aridis Pharmaceuticals Inc. Strategic Analysis Review
3.1 Aridis Pharmaceuticals Inc.- Key Strategies
3.2 Aridis Pharmaceuticals Inc.- Company Outlook Statement
3.3 Aridis Pharmaceuticals Inc.- SWOT Analysis
3.3.1 Aridis Pharmaceuticals Inc.- Key Strengths
3.3.2 Aridis Pharmaceuticals Inc.- Key Weaknesses
3.3.3 Aridis Pharmaceuticals Inc.- Potential Opportunities
3.3.4 Aridis Pharmaceuticals Inc.- Potential Threats
3.4 Aridis Pharmaceuticals Inc.- Key Competitors
4. Business Description of the Company
4.1 Aridis Pharmaceuticals Inc.- Business Overview
4.2 Aridis Pharmaceuticals Inc.- Operations by Segment
5 Products and Services Details
5.1 Aridis Pharmaceuticals Inc.- Key Products
5.2 Aridis Pharmaceuticals Inc.- Key Service Areas
5.3 Aridis Pharmaceuticals Inc.- Key Brands
6 Company Developments
6.1 Aridis Pharmaceuticals Inc.- Company History
6.2 Aridis Pharmaceuticals Inc.- Latest Developments
7 Financial Analysis
7.1 Aridis Pharmaceuticals Inc.- Income Statements
7.2 Aridis Pharmaceuticals Inc.- Balance Sheet
7.3 Aridis Pharmaceuticals Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Aridis Pharmaceuticals Inc.- Direct Competitors
8.2 Aridis Pharmaceuticals Inc.- Competitor Financial Ratios comparison
8.3 Aridis Pharmaceuticals Inc.- Competitor Stock Charts Comparison
8.4 Aridis Pharmaceuticals Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!